Likelihood of depressive symptoms in US older adults by prescribed opioid potency: National Health and Nutrition Examination Survey 2005‐2013

• Published in: International journal of geriatric psychiatry 2019-10, Vol.34 (10), p.1481-1489
• Main Authors: Brooks, Jessica M., Petersen, Curtis, Kelly, Stephanie M., Reid, Manney C.
• Format: Article
• Language: English
• Subjects: Aged; Aged, 80 and over; Analgesics; Analgesics, Opioid - administration & dosage; Analgesics, Opioid - therapeutic use; Arthritis; Codeine; Codeine - administration & dosage; Codeine - therapeutic use; Cross-Sectional Studies; depression; Depression - epidemiology; Depressive Disorder - epidemiology; Drug Prescriptions - statistics & numerical data; epidemiology; Female; Fentanyl; Geriatric psychiatry; Humans; Independent Living; Male; Mental depression; Middle Aged; Morphine; Narcotics; Nutrition Surveys; Odds Ratio; older adults; Older people; Opioids; Oxycodone; Oxycodone - administration & dosage; Oxycodone - therapeutic use; Pain; Pain - drug therapy; Pain - epidemiology; prescriptions; Prevalence; Regression analysis; Tramadol
• ISSN: 0885-6230; 1099-1166
• DOI: 10.1002/gps.5157

Objectives To investigate the relationships between depressive symptoms and opioid potency among adults aged 50 years and older reporting use of one or more prescription opioids in the past 30 days. Materials/Design Adjusted multiple linear regression models were conducted with 2005‐2013 files from a secondary cross‐sectional dataset, the National Health and Nutrition Examination Survey (NHANES). Respondents were community‐dwelling, noninstitutionalized adults 50 years or older (n = 1036). Predictor variables included a positive screen for minor depression symptoms (Patient Health Questionnaire [PHQ‐9] score greater than or equal to 5 and less than or equal to 9), moderate depression symptoms (PHQ‐9 greater than or equal to 10 and less than or equal to 14), and severe depression symptoms (PHQ‐9 greater than or equal to 15). Criterion variables included weaker‐than‐morphine analgesics (eg, codeine and tramadol) and morphine‐equivalent opioids (eg, morphine and hydrocodone), which served as the reference category, as well as stronger‐than‐morphine opioid analgesics (eg, fentanyl and oxycodone). Results Prevalence rates for symptoms of minor depression, moderate depression, and severe depression were n = 236 (22.8%), n = 135 (13.0%), and n = 122 (11.8%), respectively. Severe depression was significantly associated with high‐potency opioid use (odds ratio [OR]: 2.27; confidence interval [CI], 1.16‐4.46). In post hoc tests, severe depression remained significantly associated with high‐potency opioid use only among respondents without arthritis (OR: 5.80; CI, 1.59‐21.13). Conclusions Compared with older adults without depressive symptoms, older adults with severe depressive symptoms are more likely to be taking high‐potency opioid medications. Future prescription opioid medication research should prioritize investigations among older adults with pain‐related diagnoses, other than arthritis, reporting preexisting or new symptoms of severe depression.